Bank of Montreal’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-25,000
Closed -$6.54M 3899
2023
Q4
$6.54M Hold
25,000
﹤0.01% 1176
2023
Q3
$6.51M Hold
25,000
﹤0.01% 1180
2023
Q2
$7.48M Hold
25,000
﹤0.01% 1145
2023
Q1
$6.97M Sell
25,000
-90,000
-78% -$24.9M ﹤0.01% 1094
2022
Q4
$33.6M Buy
115,000
+14,500
+14% +$4.1M 0.01% 510
2022
Q3
$27.2K Buy
+100,500
New +$21.3M 0.01% 578
2022
Q2
Sell
-2,600
Closed -$637K 4092
2022
Q1
$637K Buy
+2,600
New +$565K ﹤0.01% 2665
2019
Q1
Sell
-35,000
Closed -$10.5M 4326
2018
Q4
$10.5M Buy
+35,000
New +$11.2M 0.01% 760

Other funds holding BIIB

Bank of Montreal's BIIB Position: Q2 2026 in Review

Bank of Montreal increased its Biogen (BIIB) stake by 34% in Q2 2026, buying an estimated $6.04M and bringing the position to 124,267 shares worth $26.8M. The position accounts for 0.01% of the portfolio, ranked #800.

Bank of Montreal first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $123M in Q4 2018. 746 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Bank of Montreal held 124,267 shares of Biogen worth $26.8M as of Q2 2026.
  • Bank of Montreal bought 31,558 Biogen shares in Q2 2026, an estimated $6.04M.
  • Biogen made up 0.01% of Bank of Montreal's portfolio in Q2 2026, its #800 holding.
  • Bank of Montreal first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's Biogen position peaked at $123M in Q4 2018.
  • 746 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.